Found 25 matching trials
Pre-Operative Treatment in REseCTable COlon CanceR
PHASE3This is an open-label, randomized, controlled, multicenter, phase III study...
Location
Charité Universitätsmedizin Berlin
Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer
PHASE2Given the growing focus on preserving organ function and the utilization of...
Status
Active Not Recruiting
Location
651 Dongfeng Road East
Chemotherapy With Cetuximab as Conversion Therapy in RAS/BRAF WT Unresectable Liver Metastasis Right-sided Colon Cancer
N/AThis study was designed as multi-center, ambispective observational trial t...
Location
Qilu hospital of Shandong University
Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases
PHASE3Evidence suggests that the addition of cetuximab or bevacizumab to doublet ...
Location
Zhongshan Hospital, Fudan University
mFOLFOXIRI Plus PD-1 Inhibitor vs mFOLFOX6 as Neoadjuvant Therapy for Locally Advanced Colon Cancer
PHASE2In patients with high-risk stage II and stage III colon cancer, curative su...
Location
Multiple Locations
Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer
PHASE2The primary aim of phase II CEIL study is to evaluate the efficacy of cetux...
Location
The First People's Hospital of Foshan
mFOLFOXIRI Versus mFOLFOX6 as Adjuvant Chemotherapy for Locally Advanced Colorectal Cancer
PHASE3The current standard treatment for locally advanced rectal cancer is still ...
Location
Gastrointestinal Hospital, Sun Yat-sen University
Neoadjuvant Treatment With mFOLFOXIRI Plus Cadonilimab (AK104) Versus mFOLFOX6 in Locally Advanced Colorectal Cancer
PHASE2Neoadjuvant chemoradiotherapy (CRT) followed by total mesenteric excision (...
Location
Gastrointestinal Hospital, Sun Yat-sen University
MRD-guided Deferred Adjuvant Therapy in Resectable Early-stage Colon Cancer
NAThe aim of this clinical trial is to test whether minimal residual disease ...
Location
Sun Yat-sen University Cancer Center
A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC
PHASE2Extramural Vascular Invasion Positive(EMVI+) is a high risk of distant meta...
Location
The First Affiliated Hospital, Zhejiang University School of Medicine